TRAZODONE HYDROCHLORIDE (trazodone hydrochloride) by Mthera Pharma is trazodone’s antidepressant action is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the cns. Approved for major depressive disorder (mdd) ( ). First approved in 2024.
Drug data last refreshed 20h ago
trazodone’s antidepressant action is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS. Trazodone is both a selective serotonin reuptake inhibitor (SSRI) and a 5HT2 receptor antagonist and the net result of this action on serotonergic…
PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese
PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
Worked on TRAZODONE HYDROCHLORIDE at Mthera Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.